Pro Share Advisors LLC Mirum Pharmaceuticals, Inc. Transaction History
Pro Share Advisors LLC
- $42.9 Billion
- Q1 2025
A detailed history of Pro Share Advisors LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 10,810 shares of MIRM stock, worth $480,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,810
Previous 13,457
19.67%
Holding current value
$480,612
Previous $556,000
12.59%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$302 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$212 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$144 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$124 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...